Clinical Trial News and Research

RSS
UK MHRA authorizes Presidio Pharmaceuticals to initiate Phase 1 clinical trial of PPI-461 for HCV

UK MHRA authorizes Presidio Pharmaceuticals to initiate Phase 1 clinical trial of PPI-461 for HCV

27 Apr 2010
Chubb WORLDcert system simplifies process for obtaining clinical trial liability insurance documentation

Chubb WORLDcert system simplifies process for obtaining clinical trial liability insurance documentation

27 Apr 2010
LCT receives grant of $500,000 for Phase II clinical trial of DIABECELL in New Zealand

LCT receives grant of $500,000 for Phase II clinical trial of DIABECELL in New Zealand

27 Apr 2010
MorphoSys AG reports Q1 results for 2010

MorphoSys AG reports Q1 results for 2010

27 Apr 2010
VertiFlex enrolls 100 patients in Superion Interspinous Spacer IDE clinical trial

VertiFlex enrolls 100 patients in Superion Interspinous Spacer IDE clinical trial

27 Apr 2010
SuperGen's total revenues for 2010 first-quarter increased to $14.4M

SuperGen's total revenues for 2010 first-quarter increased to $14.4M

27 Apr 2010
EDAP announces strategy for ongoing U.S. ENLIGHT Ablatherm-HIFU clinical trial

EDAP announces strategy for ongoing U.S. ENLIGHT Ablatherm-HIFU clinical trial

26 Apr 2010
OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva

OSI Pharmaceuticals completes enrollment in Phase III clinical trial of Tarceva

26 Apr 2010
First patient enrolled in Phase II clinical trial of E10030 for treatment of wet age-related AMD

First patient enrolled in Phase II clinical trial of E10030 for treatment of wet age-related AMD

26 Apr 2010
Phase 1/2 clinical trial of TRC105 therapy initiated for patients with castrate-resistant prostate cancer

Phase 1/2 clinical trial of TRC105 therapy initiated for patients with castrate-resistant prostate cancer

26 Apr 2010
Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

26 Apr 2010
OICR makes equity investments in three promising Ontario technologies

OICR makes equity investments in three promising Ontario technologies

26 Apr 2010
Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

26 Apr 2010
Targeted therapy based on molecular signatures for treating lung cancer

Targeted therapy based on molecular signatures for treating lung cancer

24 Apr 2010
Recent business progress at Penwest Pharmaceuticals

Recent business progress at Penwest Pharmaceuticals

24 Apr 2010
Myths and facts about pediatric cancer

Myths and facts about pediatric cancer

24 Apr 2010
HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

24 Apr 2010
Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

24 Apr 2010
OrthoAccel Technologies' AcceleDent System receives award for excellence in design

OrthoAccel Technologies' AcceleDent System receives award for excellence in design

24 Apr 2010
PMI releases 6-year malaria strategy

PMI releases 6-year malaria strategy

24 Apr 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback